Home LiteratureArticle Details
PMID: 10859330 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Abrogation of experimental colitis correlates with increased apoptosis in mice deficient for CD44 variant exon 7 (CD44v7).

The Journal of experimental medicine ·Vol. 191 ·No. 12 ·2000-06-19 ·Pages 2053-64

Wittig BM, Johansson B, Zöller M, Schwärzler C, Günthert U

Abstract

Experimental colitis in mice is characterized by infiltration of activated T helper (Th) cells and macrophages into the lamina propria. Particularly, these cells expressed CD44 variant exon 7 (CD44v7)-containing isoforms. Upregulation of CD44v7 isoforms was induced by CD40 ligation, an inflammation-driving interaction between activated Th cells and macrophages. To define the role of CD44v7 in colitis, mice bearing a targeted deletion for exon v7 were generated. In trinitrobenzene sulfonic acid-induced colitis, wild-type mice developed severe signs of persistent inflammation. Mice lacking CD44v7 initially showed unspecific inflammation, then recovered completely. The pathogenic origin was shown to reside in bone marrow-derived CD44v7(+) cells, because adoptive transfer experiments demonstrated an absolute requirement for CD44v7 on hematopoietic cells for maintenance of colitis. Interleukin (IL)-10-deficient mice, which develop a chronic Th1-driven enterocolitis, were crossbred with CD44v6/v7 null mice. In IL-10 x CD44v6/v7 double deficient mice, intestinal inflammation developed only weakly and at an older age. Analysis of cell death in the inflamed lesions revealed that mononuclear cells in the CD44v7 null infiltrates had higher rates of apoptosis than those from wild-type mice. Thus, the region encoded by CD44v7 appears to be essential for survival of effector lymphocytes, resulting in persistence of inflammation.

MeSH Terms
Adoptive Transfer Animals Apoptosis Bone Marrow Transplantation CD40 Antigens Colitis/etiology,immunology Colon/pathology Exons Hyaluronan Receptors/genetics Inflammatory Bowel Diseases/etiology,immunology Interleukin-10/genetics Intestinal Mucosa/pathology Mice Mice, Knockout Protein Isoforms/genetics Radiation Chimera Trinitrobenzenesulfonic Acid/pharmacology
Chemicals
CD40 Antigens Hyaluronan Receptors Protein Isoforms Interleukin-10 Trinitrobenzenesulfonic Acid
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Wittig B M
German Cancer Research Center, D-69120 Heidelberg, Germany.
Johansson B
Zöller M
Schwärzler C
Günthert U
References (49)
49 references, click to expand
  1. Participation in normal immune responses of a metastasis-inducing splice variant of CD44.
    Science. 1992 Jul 31;257(5070):682-5 PMID: 1496383
  2. Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity.
    J Clin Invest. 1998 Sep 15;102(6):1173-82 PMID: 9739051
  3. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation.
    J Exp Med. 1993 Aug 1;178(2):497-507 PMID: 8340756
  4. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice.
    Cell. 1993 Oct 22;75(2):203-5 PMID: 8402907
  5. Interleukin-10-deficient mice develop chronic enterocolitis.
    Cell. 1993 Oct 22;75(2):263-74 PMID: 8402911
  6. Manipulation of transgenes by site-specific recombination: use of Cre recombinase.
    Methods Enzymol. 1993;225:890-900 PMID: 8231893
  7. Expression and modulation of CD44 variant isoforms in humans.
    J Cell Biol. 1994 Jan;124(1-2):71-82 PMID: 7507492
  8. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
    Blood. 1995 May 15;85(10):2885-99 PMID: 7537983
  9. Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.
    Immunity. 1994 Oct;1(7):553-62 PMID: 7600284
  10. T cells in inflammatory bowel disease: protective and pathogenic roles.
    Immunity. 1995 Aug;3(2):171-4 PMID: 7648390
  11. CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis.
    Blood. 1995 Oct 1;86(7):2672-8 PMID: 7545465
  12. Experimental models of inflammatory bowel disease.
    Gastroenterology. 1995 Oct;109(4):1344-67 PMID: 7557106
  13. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
    J Exp Med. 1995 Nov 1;182(5):1281-90 PMID: 7595199
  14. Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis.
    Nat Med. 1995 Jun;1(6):558-63 PMID: 7585123
  15. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion.
    J Exp Med. 1996 Feb 1;183(2):693-8 PMID: 8627184
  16. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.
    Eur J Immunol. 1996 Apr;26(4):934-8 PMID: 8625991
  17. Expression of a specific subset of CD44 variant transcripts in NOD pancreatic islets.
    Diabetes. 1996 Jun;45(6):718-24 PMID: 8635643
  18. Modulation of superantigen-induced T-cell deletion by antibody anti-Pgp-1 (CD44).
    Immunology. 1996 Feb;87(2):191-7 PMID: 8698379
  19. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.
    J Exp Med. 1996 Jul 1;184(1):241-51 PMID: 8691138
  20. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation.
    J Exp Med. 1996 Aug 1;184(2):747-52 PMID: 8760829
  21. Early detachment of colon carcinoma cells during CD95(APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44.
    J Cell Biol. 1996 Aug;134(4):1089-96 PMID: 8769429
  22. Induction of fibroblast apoptosis by anti-CD44 antibody: implications for the treatment of fibroproliferative lung disease.
    Am J Pathol. 1996 Nov;149(5):1639-50 PMID: 8909253
  23. Identification of a costimulatory molecule rapidly induced by CD40L as CD44H.
    J Exp Med. 1996 Sep 1;184(3):955-61 PMID: 9064355
  24. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation.
    Immunol Today. 1997 Feb;18(2):61-4 PMID: 9057354
  25. CD40 ligation counteracts Fas-induced apoptosis of human dendritic cells.
    Int Immunol. 1997 Mar;9(3):365-72 PMID: 9088975
  26. Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells.
    Gastroenterology. 1997 Apr;112(4):1169-78 PMID: 9098000
  27. Studies with IL-10-/- mice: an overview.
    J Leukoc Biol. 1997 Apr;61(4):389-96 PMID: 9103224
  28. Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group.
    Gastroenterology. 1997 Aug;113(2):383-9 PMID: 9247454
  29. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function.
    J Exp Med. 1997 Dec 15;186(12):1985-96 PMID: 9396767
  30. CD40 ligand inhibits Fas/CD95-mediated apoptosis of human blood-derived dendritic cells.
    Eur J Immunol. 1997 Dec;27(12):3161-5 PMID: 9464801
  31. Homeostasis and self-tolerance in the immune system: turning lymphocytes off.
    Science. 1998 Apr 10;280(5361):243-8 PMID: 9535647
  32. IL-12, but not IFN-gamma, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice.
    J Immunol. 1998 Sep 15;161(6):3143-9 PMID: 9743382
  33. Influence of intron length on alternative splicing of CD44.
    Mol Cell Biol. 1998 Oct;18(10):5930-41 PMID: 9742110
  34. Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide.
    Mult Scler. 1998 Jun;4(3):147-53 PMID: 9762665
  35. Mucosal immunoregulation and inflammatory bowel disease: new insights from murine models of inflammation.
    Scand J Immunol. 1998 Nov;48(5):453-8 PMID: 9822251
  36. Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseases.
    Nat Med. 1999 Jan;5(1):42-8 PMID: 9883838
  37. Effector and regulatory lymphoid cells and cytokines in mucosal sites.
    Curr Top Microbiol Immunol. 1999;236:113-35 PMID: 9893358
  38. Control of immune pathology by regulatory T cells.
    Curr Opin Immunol. 1998 Dec;10(6):649-55 PMID: 9914214
  39. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion.
    J Immunol. 1999 Feb 15;162(4):2024-34 PMID: 9973474
  40. Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment.
    Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6896-901 PMID: 10359810
  41. CD44 variant isoforms on blood leukocytes in chronic inflammatory bowel disease and other systemic autoimmune diseases.
    Lab Invest. 1999 Jun;79(6):747-59 PMID: 10378517
  42. Importance of CD44 variant isoforms in mouse models for inflammatory bowel disease.
    Curr Top Microbiol Immunol. 1999;246:307-12; discussion 313 PMID: 10396070
  43. Requirement for CD44 in activated T cell extravasation into an inflammatory site.
    Science. 1997 Oct 24;278(5338):672-5 PMID: 9381175
  44. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator.
    EMBO J. 1998 May 15;17(10):2904-13 PMID: 9582284
  45. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses.
    Annu Rev Immunol. 1998;16:495-521 PMID: 9597139
  46. Inflammatory bowel disease: etiology and pathogenesis.
    Gastroenterology. 1998 Jul;115(1):182-205 PMID: 9649475
  47. Curative treatment of an experimentally induced colitis by a CD44 variant V7-specific antibody.
    J Immunol. 1998 Aug 1;161(3):1069-73 PMID: 9686562
  48. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis.
    J Exp Med. 1998 Sep 7;188(5):887-96 PMID: 9730890
  49. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation.
    J Exp Med. 1993 Apr 1;177(4):1209-13 PMID: 7681469
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
2000-06-19
Pages
2053-64
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2193202
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]